Subjective Symptoms after Treatment of Early Lyme Disease

American Journal of Medicine

Volumn 123, Issue 1, 2010, Pages 79-86

  Cerar, Daša ^a   Cerar, Tjaša ^b   Ružić Sabljić, Eva ^b   Wormser, Gary P ^c   Strle, Franc ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cefuroxime axetil; Control group; Doxycycline; Erythema migrans; Lyme disease; post Lyme disease symptoms; Treatment

Indexed keywords

CEFTRIAXONE; CEFUROXIME AXETIL; DOXYCYCLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; ERYTHEMA CHRONICUM MIGRANS; EUROPE; EVALUATION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; SOMNOLENCE; SYMPTOM; TREATMENT OUTCOME; VAGINA DISCHARGE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEFUROXIME; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; EARLY DIAGNOSIS; ERYTHEMA CHRONICUM MIGRANS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 72649089432     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.05.011     Document Type: Article

References (33)

1. Steere A.C., Bartenhagen N.H., Craft J.E., et al. Clinical manifestations of Lyme disease. Zentral Bakteriol Mikrobiol Hyg 263 (1986) 201-205
2. Steere A.C. Lyme disease. N Engl J Med 345 (2001) 115-125
3. Stanek G., and Strle F. Lyme borreliosis. Lancet 362 (2003) 1639-1647
4. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43 (2006) 1089-1134
5. Cairns V., and Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol 34 (2005) 1340-1345
6. Shapiro E.D., Dattwyler R., Nadelman R.B., and Wormser G.P. Response to meta-analysis of Lyme borreliosis symptoms. Int J Epidemiol 34 (2005) 1437-1439
7. Steere A.C., Hutchinson G.J., Rahn D.W., et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med 99 (1983) 22-26
8. Luger S.W., Paparone P., Wormser G.P., et al. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother 39 (1995) 661-667
9. Nadelman R.B., Luger S.W., Frank E., et al. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med 117 (1992) 273-280
10. Dattwyler R.J., Volkman D.J., Conaty S.M., et al. Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet 336 (1990) 1404-1406
11. Massarotti E.M., Luger S.W., Rahn D.W., et al. Treatment of early Lyme disease. Am J Med 92 (1992) 396-403
12. Wormser G.P., Ramanathan R., Nowakowski J., et al. Duration of antibiotic therapy for early Lyme disease. Ann Intern Med 138 (2003) 697-704
13. Dattwyler R.J., Luft B.J., Kunkel M.J., et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 337 (1997) 289-294
14. Luft B.J., Dattwyler R.J., Johnson R.C., et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans. Ann Intern Med 124 (1996) 785-791
15. Strle F., Ruzic E., and Cimperman J. Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin. J Antimicrobial Chemother 30 (1992) 543-550
16. Weber K., Wilske B., Preac-Mursic V., and Thurmayr R. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection 21 (1993) 367-372
17. Strle F., Preac-Mursic J., Cimperman J., et al. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings. Infection 21 (1993) 83-88
18. Breier F., Kunz G., Klade H., et al. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis. Infection 24 (1996) 69-72
19. Barsic B., Maretic T., Majerus L., and Strugar J. Comparison of azithromycin and doxycycline in the treatment of erythema migrans. Infection 28 (2000) 153-156
20. Feder H.M., Johnson B.J.B., O'Connell S., and Ad Hoc International Lyme Disease Group. A critical appraisal of "chronic Lyme disease.". N Engl J Med 357 (2007) 1422-1430
21. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance: Lyme disease (revised 9/96). MMWR Morb Mortal Wkly Rep 46 (1997) 20-21
22. Preac-Mursic V., Wilske B., and Schierz G. European Borrelia burgdorferi isolated from humans and ticks. Culture conditions and antibiotic susceptibility. Zentral Bakteriol Mikrobiol Hyg 263 (1986) 112-118
23. Ruzić-Sabljić E., Strle F., Cimperman J., et al. Characterisation of Borrelia burgdorferi sensu lato strains isolated from patients with skin manifestations of Lyme borreliosis residing in Slovenia. J Med Microbiol 49 (2000) 47-53
24. Ruzić-Sabljić E., Maraspin V., Lotric-Furlan S., et al. Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia. Wien Klin Wochenschr 114 (2002) 544-550
25. Wormser G.P., Liveris D., Nowakowski J., et al. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J Infect Dis 180 (1999) 720-725
26. Klempner M.S., Hu L.T., Evans J., et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345 (2001) 85-92
27. Krupp L.B., Hyman L.G., Grimson R., et al. Study and treatment of post Lyme disease (Stop-LD). A randomized double-masked clinical trial. Neurology 60 (2003) 1923-1930
28. Cluff L.E. Medical aspects of delayed convalescence. Rev Infect Dis 13 (1991) S138-S140
29. Nowakowski J., Nadelman R.B., Sell R., et al. Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med 115 (2003) 91-96
30. Strle F., Nadelman R.B., Cimperman J., et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 130 (1999) 32-36
31. Carlsson S.A., Granlund H., Jansson C., et al. Characteristics of erythema migrans in Borrelia afzelii and Borrelia garinii infections. Scand J Infect Dis 35 (2003) 31-33
32. Logar M., Ruzić-Sabljić E., Maraspin V., et al. Comparison of erythema migrans caused by Borrelia afzelii and Borrelia garinii. Infection 32 (2004) 15-19
33. Dinerman H., and Steere A.C. Lyme disease associated with fibromyalgia. Ann Intern Med 117 (1992) 281-285